Director/PDMR Shareholding

November 09, 2018

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") on 8 November 2018 that it purchased 313,957 Ordinary Shares of 1p in the capital of the Company ("Ordinary Shares") at 3.49p per Ordinary Share (the “Purchase”).  Following the purchase, Vulpes has a total direct and indirect interest in 61,446,734 equivalent to 20.82% of Proteome Sciences' total issued share capital.


Back to News